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One of the defining features of eukaryotic cells is the seg- 
regation of RNA biogenesis and DNA replication in the 
nucleus, separate from the cytoplasmic machinery for pro- 
tein synthesis. Integration of the activities of the nucleus 
and cytoplasm requires the continuous transport of pro- 
teins, RNAs, and small molecules between these two com- 
partments. Nucleocytoplasmic transport is mediated by 
nuclear pore complexes (NPCs), large supramolecular 
structures that span the nuclear envelope (reviewed by 
Rout and Wente, 1994). NPCs contain aqueous channels 
with a diameter of - 10 nm, which allow ions, metabolites, 
and small proteins to diffuse passively between the nu- 
cleus and cytoplasm. Most proteins and RNAs are too 
large to cross the NPC by passive diffusion at physiologi- 
cally relevant rates. Instead, they are transported through 
a gated transport channel in the NPC by active mecha- 
nisms, which are saturable and energy dependent and 
involve specific signals on the transported molecules (re- 
viewed by Izaurralde and Mattaj, 1995; Melchior and Ger- 
ace, 1995). 
While substantial insight into the molecular basis for 
nuclear protein import has been obtained recently, nuclear 
export remains poorly understood. However, four papers 
in this issue of Cell (Wen et al., 1995; Fischer et al., 1995; 
Bogerd et al., 1995; Stutz et al., 1995) characterize molec- 
ular signals and their interacting components involved in 
the nuclear export of protein and RNA and herald a new 
period in the study of nuclear export mechanisms. 
Molecular Signals for Nuclear Import and Export 
A watershed for the analysis of nuclear protein import was 
the discovery that short amino acid stretches termed nu- 
clear localization signals (N LSs) specify the nuclear import 
of many proteins. While N LSs lack a strict consensus, they 
are usually highly enriched in basic amino acids (reviewed 
by Dingwall and Laskey, 1991). NLSs containing both sin- 
gle and bipartite stretches of basic residues have been 
described (Figure 1), These N LSs can function when trans- 
planted to nonnuclear proteins, either by inserting NLS- 
specifying codons into cDNAs or by coupling synthetic 
peptides containing NLSs to folded proteins. 
Characterization of nuclear export signals (NESs) has 
lagged considerably behind analysis of NLSs. This partly 
is due to the experimental difficulty of studying nuclear 
export, but also relates to the complex nature of many of 
the molecular species that are exported from the nucleus 
(discussed by Izaurralde and Mattaj, 1995). The RNA sub- 
strates for nuclear export are probably all transported as 
RNA-protein (RNP) complexes. Many or all of these RNPs 
contain multiple polypeptides, so it is difficult o know the 
precise composition of the substrate that is actually trans- 
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ported. Moreover, it is not known whether the molecular 
signals that interact with the nuclear transport machinery 
reside in the RNAs themselves or in the proteins that are 
bound to the RNAs (see Izaurralde and Mattaj, 1995). 
A new perspective on the problem of nuclear export 
emerged recently with the characterization of specific pro- 
teins that rapidly shuttle between the nucleus and cyto- 
plasm, which have the potential to bear NESs as well as 
import signals. These shuttling species include RNA- 
binding proteins, such as the hnRNP A1 protein (Pifiol- 
Roma and Dreyfuss, 1992) and the HIV-1 Rev protein (Kal- 
land et al., 1994; Meyer and Malim, 1994), as well as 
proteins that have no obvious interaction with RNAs, in- 
cluding certain transcriptional activators (Madan and De- 
Franco, 1993) and hsc70 (Mandell and Feldherr, 1990). 
A detailed analysis of the nuclear trafficking pathways of 
two shuttling proteins, the cAMP-dependent protein ki- 
nase (PKA) and Rev, has now led to the definition of short 
protein sequences responsible for rapid nuclear export. 
NES of Protein Kinase Inhibitor 
The inactive PKA holoenzyme, consisting of two regula- 
tory (R) and two catalytic (C) subunits, is localized in the 
cytoplasm (discussed by Harootunian et al., 1993). En- 
zyme activation is triggered by the binding of cAMP to 
the R subunits, which dissociates the holoenzyme and 
releases an R2 dimer and monomeric active C subunits 
that can act on nuclear and cytoplasm targets. 
Previous studies involving microinjection of fluores- 
cently labeled C subunit into cultured mammalian cells 
indicated that this protein (41 kDa) can enter and exit the 
nucleus by passive diffusion, and at equilibrium it is some- 
what more .concentrated in the nucleus than in the cyto- 
plasm (Harootunian et al., 1993). However, when cells pre- 
viously injected with C subun it are given a second injection 
with protein kinase inhibitor (PKI), a naturally occurring 
75 amino acid inhibitor of PKA, the C subunit is rapidly 
Nuclear Localization Signals 
SV40 T antigen 
nucleoplasmin 
PKKKRKV 
KRPAATKKAGQAKKKK 
Nuclear Export Signals 
PKI LALKLAG LD I 
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Figure 1. Signals for Nuclear Transport 
All nuclear transport signals in proteins that are well characterized are 
short stetches of amino acids. The NLSs of the SV40 T antigen and 
nucleoplasmin given as examples are discussed by Dingwall and 
Laskey (1991), the sequence of the PKI NES is from Wen et al. (1995), 
and the sequence of the Rev NES is from Fischer et al. (1995) and 
Wen et al. (1995). Residues that have been identified by mutagenesis 
as particularly important for transport are underlined. The leucines in 
the Rev sequence are important for Rev function (see Bogerd et al., 
1995), but the sequence requirements for export have not been sys- 
tematically analyzed. 
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depleted from the nucleus as a complex with PKI (Fantozzi 
et al., 1994). The export of the C-PKI complex in this case 
is dependent on temperature and energy and appears to 
be an active process. 
Interestingly, the NES responsible for active transport 
out of the nucleus resides on PKI itself (Wen et al., 1994). 
Wen et al. (1995) were able to assign the nuclear export 
activity to a 10 amino acid internal sequence of PKI (resi- 
dues 37-46; Figure 1) by microinjecting fluorescently la- 
beled fusion proteins containing different fragments of PKI 
into the nucleus and following their accumulation in the 
cytoplasm. This region is distinct from an amino-terminal 
segment of the protein involved in inhibition of C subunit 
activity. The NES of PKI is rich in leucine and other hy- 
drophobic residues and bears no similarity to NLSs. Ala- 
nine substitution mutagenesis showed that specific leu- 
cine residues and an isoleucine were especially important 
for the activity of this region (Figure 1). 
Rev NES and RNA Export Pathways 
Independent insight on the nature of NESs emerged from 
studies of the HIV-1 Rev protein, a 116 amino acid polypep- 
tide required for virus reproduction (reviewed by Cullen, 
1992). Rev is responsible for the nuclear export of un- 
spliced and partially spliced HIV mRNAs encoding the viral 
structural proteins, which are restricted to the nucleus in 
the absence of Rev. Two essential functional regions have 
been defined in Rev: an amino-terminal domain that inter- 
acts with a specific RNA stem-loop structure on the target 
mRNAs, the Rev response element (RRE), and a more 
carboxy-terminal "activation" domain containing an -10  
amino acid leucine-rich core. The activation domain, 
which is dispensible for binding to the RRE, has been 
strongly suggested to interact with one or more cellular 
cofactors. It has been controversial whether Rev acts by 
inhibiting the splicing of RRE-containing transcripts and 
thereby freeing these molecules for nuclear export, by di- 
rectly promoting the nuclear export of RRE-containing 
RNAs, or both (see Cullen, 1992). Strong evidence for a 
direct involvement of Rev in nuclear export was provided 
recently by the finding that in Xenopus oocytes, Rev medi- 
ates the rapid nuclear export of microinjected RRE- 
containing RNAs, including RNAs lacking intron se- 
quences (Fischer et al., 1994). 
Fischer et al. (1995) analyzed the possibility that the 
leucine-rich core of the Rev activation domain is an NES 
by coupling a peptide containing nine amino acids of this 
region to bovine serum albumin (BSA) and injecting this 
conjugate into the nuclei of Xenopus oocytes and mamma- 
lian cultured cells. They found that this peptide, but not 
a nonfunctional mutant form of the activation domain, me- 
diates rapid nuclear export that is saturable and tempera- 
ture dependent. The Rev activation domain also mediates 
rapid nuclear export when inserted into a fusion protein, 
as reported by Wen et al. (1995). Thus, the leucine-rich 
activation domain of Rev, like the leucine-rich sequence 
of PKI, is an NES (Figure 1). This indicates that certain 
amino acid stretches enriched in hydrophobic residues 
(especially leucines) define one class of NESs responsible 
for transport out of the nucleus (Figure 1). 
Two characteristics of these leucine-type NESs are 
noteworthy, as they resemble features previously de- 
scribed for NLSs (see Dingwall and Laskey, 1991). First, 
nuclear export mediated by these sequences is a rapid 
and apparently active process (Fischer et al., 1995; Wen 
et al., 1995). The rapid kinetics is distinct from the slow 
nuclear export kinetics seen for some proteins lacking 
overt NESs, which may exit the nucleus by passive diffu- 
sion or by low affinity interactions with proteins bearing 
specific export signals (Schmidt-Zachmann et al., 1993). 
Second, complex tertiary structure is not required for the 
activity of these sequences, since synthetic peptides con- 
taining the NESs are sufficient to mediate rapid nuclear 
export of large carrier proteins to which they are chemically 
coupled, and the NESs are functional when located at 
either the amino or carboxyl terminus of various fusion 
proteins (Wen et al., 1995). 
In microinjection studies with Xenopus oocytes, the Rev- 
mediated nuclear export of an RRE-containing RNA is 
strongly competed by BSA coupled with the Rev NES pep- 
tide (Fischer et al., 1995). This and other work indicate 
that the nuclear export of RRE-containing RNA is driven 
by the NES of Rev. These studies provide an illustration 
of an NES for RNA export that is located on a specific 
RNA-binding protein and promote the idea that protein- 
based NESs may be a common feature of nuclear RNA 
export. 
To examine whether the nuclear export pathway speci- 
fied by the Rev NES was shared by other cellular RNAs, 
Fischer et al. (1995) analyzed the nuclear export of a vari- 
ety of RNA substrates injected into oocyte nuclei in the 
presence of competitor BSA coupled with the Rev NES. 
They find that the Rev NES strongly and specifically com- 
petes for the nuclear export of 5S rRNA and U1 snRNA, 
but does not detectably compete for the nuclear export 
of two different mRNAs, a tRNA, and ribosomes. This indi- 
cates that the pathway for Rev export is also used by sev- 
eral cellular RNAs and predicts that 5S rRNA and U1 
snRNA have bound proteins with leucine-type NESs. Con- 
sistent with this, TFIIIA, a protein associated with 5S rRNA 
and implicated in its export (Guddat et al, 1990), contains 
a leucine-rich sequence similar to the Rev NES (see 
Fischer et al., 1995). The NES of capped U snRNAs may 
be present in a cap-binding protein complex that has re- 
cently been directly implicated in their nuclear export 
(Izaurralde et al., 1995). In light of these findings, it will 
be of great interest o determine whether shuttling proteins 
bound to mRNAs, ribosomal subunits, and tRNAs contain 
distinct classes of NESs. 
Cellular Factors That Interact with the Bey NES 
The cellular cofactor that interacts with the Rev activation 
domain appears to be highly conserved, because Rev is 
functional in mediating RRE-dependent transactivation of 
reporter genes in budding yeast (Stutz and Rosbash, 
1994) as well as in mammalian cells. Yeast two-hybrid 
screens have now been used to search for such activation 
domain cofactors in human cells (Bogerd et al., 1995) and 
yeast (Stutz et al., 1995). Bogerd et al. identified a single 
human protein, termed Rab, which interacts with Rev as 
well as the functionally equivalent proteins of several other 
retroviruses, including the Rex protein of HTLV-I. Compel- 
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ling evidence for a specific interaction of Rab with the 
activation domain of Rev was provided by the analysis of a 
large set of scanning missense mutations in the activation 
domain. Similarly, Stutz et al. have identified a single yeast 
protein, designated Riplp, that interacts with intact Rev 
and Rex as well as with a 30 amino acid segment con- 
taining the Rev activation domain, but not with two activa- 
tion domain mutants of Rev. 
Bogerd et al. (1995) investigated the biological rele- 
vance of the Rab-Rev interaction with a series of transacti- 
vation studies in mammalian cells. Using a chtorampheni- 
col acetyltransferase (CAT) reporter assay that measured 
the assembly of a transcription-activating protein complex 
on an RNA target, they found that Rab functionally inter- 
acts with Rev in an activation domain-dependent manner 
when the latter is bound to the RRE. Most significantly, 
they found that under conditions of low Rev or Rex expres- 
sion that limited the production of an RRE-dependent viral 
structural protein, overexpression of Rab could substan- 
tially enhance the expression of this reporter. The positive 
effect of Rab overexpression strongly argues that Rab is 
a physiological participant in the Rev pathway. Stutz et 
al. (1995) provide evidence for a role of Riplp in the Rev 
pathway in yeast with the finding that the activity of Rev 
in transactivation assays is diminished by disruption of 
the RIP1 gene, which otherwise yields viable cells with no 
obvious growth phenotypes. The finding that some Rev 
activity remains after RIP1 disruption could be explained 
by the functional redundancy of RIP1 with other yeast pro- 
teins that interact with Rev. 
From DNA sequencing, both the 58 kDa Rab (Bogerd 
et al., 1995) and the 42 kDa Rip1 p (Stutz et al., 1995) were 
found to be novel polypeptides that are rich in phenylala- 
nine, serine, and threonine residues. Rab and Riplp con- 
tain the so-called FG dipeptide motif iterated 10 and 27 
times, respectively, but otherwise have no obvious primary 
sequence homology. Multiple FG repeats also are present 
in a subset of yeast and vertebrate nucleoporins (NPC 
polypeptides; reviewed by Rout and Wente, 1994), as well 
as a number of proteins that have no apparent relationship 
to nuclear transport, such as keratins. Interestingly, some 
FG-containing nuc!eoporins appear to participate directly 
in nuclear transport through interactions with cytosolic 
transport factors (Paschal and Gerace, 1995; Radu et al., 
1995). Immunofluorescence microscopy indicates that hu- 
man Rab is localized throughout he nucteoplasm and ap- 
parently is not a nucleoporin, while yeast Riplp is concen- 
trated at the NPC. Since some nuclear transport factors 
that are mostly cytosolic have been shown to be concen- 
trated at the NPC in vivo (e.g., Chi et al., 1995), it is at 
present uncertain whether Riplp is a nucleoporin or a solu- 
ble factor that interacts with the NPC. 
While the evidence is strong that human Rab and bud- 
ding yeast Riplp act in the same pathway, it is unclear 
whether they are functionally equivalent. A direct interac- 
tion between Rev and either of these binding partners has 
not been demonstrated using purified proteins. It is im- 
portant to note that the interactions between Rev and ei- 
ther Rab or Riplp measured in two-hybrid assays may be 
indirect, as they could be mediated by a linker protein(s) 
provided by the host cell. This consideration also applies 
to the finding that two previously characterized yeast 
nucleoporins containing FG repeats, Rat7p and Nupl00p, 
also interact with Rev in the two-hybrid assay, albeit more 
weakly than Rip1 p (Stutz et al., 1995). The conserved nu- 
clear protein elF-5A has been found to interact specifically 
with the Rev activation domain by peptide cross-linking 
and appears to have a role in transactivation (Ruhl et al., 
1993), so it is another candidate for a Rev-binding factor 
involved in export. 
Role of Shuttling Receptors in Nuclear Transport 
If Rab and Riplp are found to interact directly with the 
NES of Rev, these proteins would be good candidates for 
receptors for Rev and other proteins bearing leucine-type 
NESs. Insight on how such NES receptors could function 
comes from recent studies on nuclear protein import, a 
process that is mediated by multiple cytosolic factors act- 
ing in concert with proteins of the NPC (reviewed by Mel- 
chior and Gerace, 1995). Among the best-characterized 
cytosolic factors are the NLS receptors (also termed im- 
portin and karyopherin), a group of related proteins that 
specifically bind basic-type NLSs (reviewed by Adam, 
1995). 
NLS receptors are suggested to function as shuttling 
carriers that transfer NLS-containing cargo from the cyto- 
plasm to the NPC and subsequently to the nuclear interior 
(Figure 2; see Gerace, 1992). During transport through 
the NPC, the NLS receptor-cargo complex appears to 
undergo stepwise movement between a.number of dis- 
crete NPC components, including peripheral and internal 
binding sites and the central gated channel (discussed 
by Melchior and Gerace, 1995). Since the NPC is largely 
symmetrical with respect to nucleoplasmic and cyto- 
plasmic "halves" and the same central channel is used for 
both nuclear import and export (reviewed by Pant~ and 
Aebi, 1993), the general mechanisms of nuclear export 
are likely to be similar to those of nuclear import. Thus, 
by analogy to the apparent functions of NLS receptors, 
NES receptors may be shuttling carriers that operate in 
the nuclear-to-cytoplasmic direction (Figure 2). 
Two different types of NES receptor-mediated export 
can be envisaged. In one mechanism (called direct in Fig- 
ure 2), the cargo that is exported to the cytoplasm would 
be the NES-containing components, which directly inter- 
act with NES receptors. This situation could describe the 
export of certain nuclear proteins transported to the cyto- 
plasm in the absence of bound RNA, such as the glucocor- 
ticoid receptor (Madan and DeFranco, 1993). In a second 
mechanism (called adaptor mediated in Figure 2), the 
cargo that is exported to the cytoplasm would be linked 
to the NES receptors by NES-containing adaptors, which 
shuttle between the nucleus and cytoplasm like the NES 
receptors. This second situation applies to the nuclear 
export of the C subunit and RRE-containing RNAs, where 
the NES-containing adaptors are PKI and Rev, respec- 
tively. Adaptor-mediated transport may be the prevalent 
mechanism for nuclear export of RNAs (see above). 
It should be noted that the interaction of nuclear trans- 
port signals with soluble carrier proteins rather than di- 
rectly with NPC proteins has a number of advantages 
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Figure 2. Model for the Role of Shuttling Com- 
ponents in Nuclear Transport 
(Left) Nuclear import is apparently mediated by 
shuttling receptors that bind to the NLS-con- 
taining cargo. These receptors, together with 
other cytosolic factors (not shown here), se- 
quentially interact with several regions of the 
NPC (see Melchior and Gerace, 1995). 
(Right) Because of the symmetry of the NPC 
and the mechanics of transport, it is speculated 
that NES beceptors also serve as shuttling car- 
riers (see text). The NES-containing compo- 
nents that interact with receptors could either 
be the cargo that is exported to the cytoplasm 
(shown on left) or shuttling adaptors that attach 
the cargo to the NES receptors (shown on 
right). It is possible that shuttling adaptors also 
are involved in nuclear import of certain macro- 
molecules, but no examples of this have yet 
been described. 
related to transport mechanics. Carrier proteins would pro- 
vide a much larger three-dimensional surface than NLSs 
and NESs themselves for interactions with other soluble 
factors and the NPC proteins that accomplish transfer be- 
tween sequential NPC-binding sites. Also, carriers with a 
modular design could allow structurally diverse import and 
export signals to use a common transport apparatus in 
the central gated channel of the NPC. Investigation of the 
dynamics of shuttling carriers could be key to understand- 
ing the functional properties of the NPC, including the 
activity of the gated transport channel. 
Future Prospects 
A broad challenge for the future is the definition of addi- 
tional classes of signals that account for the nuclear export 
of proteins and RNAs. In cases in which RNA export is 
driven by protein-based NESs, the problem of RNA export 
will largely be reduced to one of protein export. This could 
greatly simplify the experimental analysis. Regulation of 
the activity of certain NLSs is now well documented (dis- 
cussed by Gerace, 1992), and it will be particularly im- 
portant to investigate how the activity of nuclear transport 
signals on shuttling proteins might be regulated. The inde- 
pendent regulation of NESs and NLSs on a shuttling pro- 
tein could dramatically change its nuclear/cytoplasmic 
concentration ratio and thereby could have profound influ- 
ences on cellu lar physiology. The results discussed above 
now provide a solid framework for thinking about the prob- 
lem of nuclear export and indicate that molecular analysis 
of nuclear export mechanisms is finally coming of age. 
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